Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance.

Autor: Wykoff CC; Retinal Consultants of Texas, Houston, Texas., Avery RL; California Retina Consultants, Santa Barbara, California., Barakat MR; Retinal Consultants of Arizona, Phoenix, Arizona.; University of Arizona College of Medicine - Phoenix, Phoenix, Arizona., Boyer DS; Retina-Vitreous Associates Medical Group, Los Angeles, California., Brown DM; Retinal Consultants of Texas, Houston, Texas., Brucker AJ; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Cunningham ET Jr; Department of Ophthalmology, California Pacific Medical Center, San Francisco, California.; The Francis I Proctor Foundation, UCSF School of Medicine, San Francisco, California.; Department of Ophthalmology, Stanford University School of Medicine, Stanford, California.; West Coast Retina Medical Group, San Francisco, California., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Holekamp NM; Pepose Vision Institute, St. Louis, Missouri.; Roche Pharmaceuticals, Basel, Switzerland., Kaiser PK; Cole Eye Institute, Cleveland, Ohio., Khanani AM; Sierra Eye Associates, Reno, Nevada.; University of Nevada, Reno School of Medicine, Reno, Nevada., Kim JE; Medical College of Wisconsin, Milwaukee, Wisconsin., Demirci H; Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan., Regillo CD; Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania., Yiu GC; University of California, Davis Health, Sacramento, California; and., Ciulla TA; Chief Medical Advisor and Chair of Scientific Advisory Board, Clearside Biomedical, Alpharetta, Georgia.

Publikováno v: Retina (Philadelphia, Pa.) [Retina] 2024 Jun 01; Vol. 44 (6), pp. 939-949.

Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents.

Autor: Ayoup MS; Department of Chemistry, College of Science, King Faisal University P.O. Box 400 Al-Ahsa 31982 Saudi Arabia mayoup@kfu.edu.sa mohammedsalahayoup@gmail.com.; Chemistry Department, Faculty of Science, Alexandria University P.O. Box 426 Alexandria 21321 Egypt., Barakat MR; Chemistry Department, Faculty of Science, Alexandria University P.O. Box 426 Alexandria 21321 Egypt., Abdel-Hamid H; Chemistry Department, Faculty of Science, Alexandria University P.O. Box 426 Alexandria 21321 Egypt., Emam E; General Q.C Manager, Alexandria company for pharmaceuticals Alexandria 21521 Egypt., Al-Faiyz YS; Department of Chemistry, College of Science, King Faisal University P.O. Box 400 Al-Ahsa 31982 Saudi Arabia mayoup@kfu.edu.sa mohammedsalahayoup@gmail.com., Masoud AA; Bio-screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University 21511 Alexandria Egypt., Ghareeb DA; Bio-screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University 21511 Alexandria Egypt.; Center of Excellence for Drug Preclinical Studies (CE-DPS), Pharmaceutical and Fermentation Industry Development Center, City of Scientific Research & Technological Applications (SRTA-city) New Borg El Arab Alexandria Egypt., Sonousi A; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University P.O. Box 11562, Kasr El-Aini Street Cairo Egypt asmaa.kassab@pharma.cu.edu.eg.; University of Hertfordshire hosted by Global Academic Foundation, New Administrative Capital Cairo Egypt., Kassab AE; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University P.O. Box 11562, Kasr El-Aini Street Cairo Egypt asmaa.kassab@pharma.cu.edu.eg.

Publikováno v: RSC medicinal chemistry [RSC Med Chem] 2024 Apr 09; Vol. 15 (6), pp. 2080-2097. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).

Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease.

Autor: Xu L; Independent Research Consultant, Contrator for RevOpsis Therapeutics, Inc., San Carlos, California., Prentice JR; Springfield Clinic Eye Institute, Springfield, Illinois., Velez-Montoya R; Retina Department. Asociacion para Evitar la Ceguera en Mexico IAP, Mexico City, Mexico., Sinha A; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri., Barakat MR; Retinal Consultants of Arizona, and University of Arizona College of Medicine, Phoenix, Arizona., Gupta A; Vanderbilt School of Medicine, Nashville, Tennessee., Lowenthal R; Springfield Clinic Eye Institute, Springfield, Illinois., Khanani AM; Sierra Eye Associates, and University of Nevada, Reno School of Medicine, Reno, Nevada., Kaiser PK; Cole Eye Institute, Cleveland, Ohio., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Jones A; Sue Anschutz Rodgers Eye Center, University of Colorado, Aurora, Colorado., Morgenstern JL; Sue Anschutz Rodgers Eye Center, University of Colorado, Aurora, Colorado., Strong Caldwell A; Sue Anschutz Rodgers Eye Center, University of Colorado, Aurora, Colorado., Mueller N; Sue Anschutz Rodgers Eye Center, University of Colorado, Aurora, Colorado., Quiroz-Mercado H; Retina Department. Asociacion para Evitar la Ceguera en Mexico IAP, Mexico City, Mexico., Huvard M; University of Michigan Kellogg Eye Center, Ann Arbor, Michigan., Olson JL; Sue Anschutz Rodgers Eye Center, University of Colorado, Aurora, Colorado., Bhatt R; Independent Research Consultant, Contrator for RevOpsis Therapeutics, Inc., San Carlos, California., Bhandari R; Springfield Clinic Eye Institute, Springfield, Illinois.

Publikováno v: Ophthalmology science [Ophthalmol Sci] 2024 Jan 18; Vol. 4 (4), pp. 100467. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).